Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Apellis Pharmaceuticals Inc (NASDAQ: APLS) was $17.67 for the day, up 1.26% from the previous closing price of $17.45. In other words, the price has increased by $1.26 from its previous closing price. On the day, 2.55 million shares were traded.
Ratios:
Our analysis of APLS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 4.08. In the meantime, Its Debt-to-Equity ratio is 2.86 whereas as Long-Term Debt/Eq ratio is at 2.82.
On May 09, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $23.
On April 29, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $44.Cantor Fitzgerald initiated its Overweight rating on April 29, 2025, with a $44 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 12 ’25 when Townsend Adam J. bought 220,961 shares for $17.76 per share.
Chopas James George sold 183 shares of APLS for $4,543 on Mar 17 ’25. The VP/Chief Accounting Officer now owns 47,955 shares after completing the transaction at $24.82 per share. On Mar 17 ’25, another insider, Chopas James George, who serves as the Officer of the company, bought 183 shares for $24.82 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.86 while its Price-to-Book (P/B) ratio in mrq is 13.52.
Stock Price History:
Over the past 52 weeks, APLS has reached a high of $43.99, while it has fallen to a 52-week low of $16.10. The 50-Day Moving Average of the stock is -14.04%, while the 200-Day Moving Average is calculated to be -38.56%.
Shares Statistics:
A total of 125.66M shares are outstanding, with a floating share count of 103.40M. Insiders hold about 17.73% of the company’s shares, while institutions hold 98.84% stake in the company.
